Zurich Cantonal Bank’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $355K | Hold |
4,285
| – | – | ﹤0.01% | 2115 |
|
|
2026
Q1 | $330K | Buy |
+4,285
| New | +$334K | ﹤0.01% | 2049 |
|
|
2025
Q4 | – | Sell |
-2,971
| Closed | -$257K | – | 2602 |
|
|
2025
Q3 | $272K | Hold |
2,971
| – | – | ﹤0.01% | 2048 |
|
|
2025
Q2 | $194K | Hold |
2,971
| – | – | ﹤0.01% | 2152 |
|
|
2025
Q1 | $199K | Hold |
2,971
| – | – | ﹤0.01% | 2107 |
|
|
2024
Q4 | $164K | Hold |
2,971
| – | – | ﹤0.01% | 2238 |
|
|
2024
Q3 | $177K | Buy |
2,971
+579
| +24% | +$35.3K | ﹤0.01% | 2173 |
|
|
2024
Q2 | $152K | Sell |
2,392
-2
| -0.1% | -$130 | ﹤0.01% | 2174 |
|
|
2024
Q1 | $165K | Sell |
2,394
-335
| -12% | -$20.2K | ﹤0.01% | 2162 |
|
|
2023
Q4 | $150K | Sell |
2,729
-609
| -18% | -$33.5K | ﹤0.01% | 2243 |
|
|
2023
Q3 | $194K | Buy |
3,338
+1,015
| +44% | +$58.6K | ﹤0.01% | 1991 |
|
|
2023
Q2 | $125K | Buy |
2,323
+902
| +63% | +$40K | ﹤0.01% | 2227 |
|
|
2023
Q1 | $56.4K | Buy |
1,421
+627
| +79% | +$26.4K | ﹤0.01% | 2556 |
|
|
2022
Q4 | $31.9K | Hold |
794
| – | – | ﹤0.01% | 2696 |
|
|
2022
Q3 | $26K | Hold |
794
| – | – | ﹤0.01% | 2750 |
|
|
2022
Q2 | $24K | Hold |
794
| – | – | ﹤0.01% | 2770 |
|
|
2022
Q1 | $22K | Hold |
794
| – | – | ﹤0.01% | 2657 |
|
|
2021
Q4 | $37K | Hold |
794
| – | – | ﹤0.01% | 2796 |
|
|
2021
Q3 | $26K | Hold |
794
| – | – | ﹤0.01% | 2761 |
|
|
2021
Q2 | $28K | Hold |
794
| – | – | ﹤0.01% | 2549 |
|
|
2021
Q1 | $29K | Hold |
794
| – | – | ﹤0.01% | 2498 |
|
|
2020
Q4 | $23K | Hold |
794
| – | – | ﹤0.01% | 2564 |
|
|
2020
Q3 | $22K | Hold |
794
| – | – | ﹤0.01% | 2475 |
|
|
2020
Q2 | $26K | Hold |
794
| – | – | ﹤0.01% | 2408 |
|
|
2020
Q1 | $32K | Hold |
794
| – | – | ﹤0.01% | 2144 |
|
|
2019
Q4 | $49K | Hold |
794
| – | – | ﹤0.01% | 2157 |
|
|
2019
Q3 | $58K | Hold |
794
| – | – | ﹤0.01% | 1929 |
|
|
2019
Q2 | $65K | Buy |
794
+559
| +238% | +$39.8K | ﹤0.01% | 1893 |
|
|
2019
Q1 | $17K | Hold |
235
| – | – | ﹤0.01% | 2452 |
|
|
2018
Q4 | $11K | Hold |
235
| – | – | ﹤0.01% | 2540 |
|
|
2018
Q3 | $13K | Hold |
235
| – | – | ﹤0.01% | 2526 |
|
|
2018
Q2 | $16K | Hold |
235
| – | – | ﹤0.01% | 2450 |
|
|
2018
Q1 | $14K | Hold |
235
| – | – | ﹤0.01% | 2458 |
|
|
2017
Q4 | $15K | Hold |
235
| – | – | ﹤0.01% | 2455 |
|
|
2017
Q3 | $12K | Hold |
235
| – | – | ﹤0.01% | 2385 |
|
|
2017
Q2 | $11K | Hold |
235
| – | – | ﹤0.01% | 2406 |
|
|
2017
Q1 | $12K | Hold |
235
| – | – | ﹤0.01% | 2440 |
|
|
2016
Q4 | $14K | Hold |
235
| – | – | ﹤0.01% | 2366 |
|
|
2016
Q3 | $16K | Hold |
235
| – | – | ﹤0.01% | 2294 |
|
|
2016
Q2 | $13K | Hold |
235
| – | – | ﹤0.01% | 2279 |
|
|
2016
Q1 | $8K | Hold |
235
| – | – | ﹤0.01% | 2411 |
|
|
2015
Q4 | $11K | Hold |
235
| – | – | ﹤0.01% | 2325 |
|
|
2015
Q3 | $9K | Buy |
+235
| New | +$13.4K | ﹤0.01% | 2089 |
|
Other funds holding ANIP
SCM
TCM
GACM
Zurich Cantonal Bank's ANIP Position: Q2 2026 in Review
Zurich Cantonal Bank held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 4,285 shares worth $355K. The position accounts for ﹤0.01% of the portfolio, ranked #2115.
Zurich Cantonal Bank first reported a position in ANIP in Q3 2015 and has held it in 43 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.
- Zurich Cantonal Bank held 4,285 shares of ANI Pharmaceuticals worth $355K as of Q2 2026.
- Zurich Cantonal Bank left its ANI Pharmaceuticals share count unchanged in Q2 2026.
- ANI Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2115 holding.
- Zurich Cantonal Bank first reported a position in ANI Pharmaceuticals in Q3 2015 and has held it in 43 quarters since.
- 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.